Booting Earth Optimization System
Thank you for your patience. Your civilization is very important to us.
Arterial Switch Operation (ASO) for Transposition of Great Arteries (TGA)
Treatment for Congenital heart anomalies
Effectiveness
95%
Safety Score
45%
Clinical Trials
1
Participants
50K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
45
DangerousModerateSafe
Treatment Details
Time to Effect
Immediate (hemodynamic correction), critical early recovery, long-term monitoring
Treatment Duration
Single procedure (neonatal), lifetime specialized cardiac care
Evidence Quality
HIGHConfidence Score
98%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$200
Monitoring:$1,500
Side Effect Mgmt:$400
Total Annual:$2,100
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTICER
$40,000/QALY
QALYs Gained
25
Outcome-Based Costs
Cost per Responder
$2,210.53
Cost per Remission
$2,333.33
Arterial Switch Operation (ASO) for Transposition of Great Arteries (TGA) Outcomes
for Congenital heart anomalies
Efficacy Outcomes
Overall Effectiveness
+95%
Response Rate
+95%
Remission Rate
+90%
Common Side Effects
Coronary artery stenosis
+5%
Supravalvular pulmonary stenosis
+10%
Neoaortic root dilation/regurgitation
+15%
Arrhythmias
+5%
Mortality
+3%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov